These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 12503037

  • 1. An analysis of prognostic factors and the five-year survival rate in childhood acute lymphoblastic leukemia.
    Karimi M, Yarmohammadi H, Sabri MR.
    Med Sci Monit; 2002 Dec; 8(12):CR792-6. PubMed ID: 12503037
    [Abstract] [Full Text] [Related]

  • 2. Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis Of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE).
    Donadieu J, Auclerc MF, Baruchel A, Perel Y, Bordigoni P, Landman-Parker J, Leblanc T, Cornu G, Sommelet D, Leverger G, Schaison G, Hill C, French Acute Lymphoblastic Leukaemia Group (FRALLE).
    Br J Cancer; 2000 Dec; 83(12):1617-22. PubMed ID: 11104555
    [Abstract] [Full Text] [Related]

  • 3. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A, Zimmermann M, Reiter A, Gadner H, Odenwald E, Harbott J, Ludwig WD, Riehm H, Schrappe M.
    Klin Padiatr; 2005 Dec; 217(6):310-20. PubMed ID: 16307416
    [Abstract] [Full Text] [Related]

  • 4. Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial.
    Hunault M, Truchan-Graczyk M, Caillot D, Harousseau JL, Bologna S, Himberlin C, Guyotat D, Berthou C, Casassus P, Baranger L, Béné MC, Ifrah N, Gyan E, GOELAMS Group.
    Haematologica; 2007 Dec; 92(12):1623-30. PubMed ID: 18055985
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of central nervous system involvement at diagnosis of childhood T-cell acute lymphoblastic leukemia.
    Jaing TH, Yang CP, Hung IJ, Tsay PK, Tseng CK, Chen SH.
    Pediatr Blood Cancer; 2005 Aug; 45(2):135-8. PubMed ID: 15704218
    [Abstract] [Full Text] [Related]

  • 6. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P, Landman-Parker J, Cayuela JM, Asnafi V, Labopin M, Gandemer V, Perel Y, Michel G, Leblanc T, Schmitt C, Fasola S, Hagemejier A, Sigaux F, Auclerc MF, Douay L, Leverger G, Baruchel A.
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic effectiveness of the ALL-XH-99 protocol for childhood acute lymphoblastic leukemia.
    Wang YR, Jin RM, Xu JW, Xiao Y, Zhou DF, Zhang ZQ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):1-4. PubMed ID: 18289459
    [Abstract] [Full Text] [Related]

  • 8. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D, Chelghoum Y, Le QH, Elhamri M, Michallet M, Thomas X.
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [Abstract] [Full Text] [Related]

  • 9. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group.
    Matsuzaki A, Nagatoshi Y, Inada H, Nakayama H, Yanai F, Ayukawa H, Kawakami K, Moritake H, Suminoe A, Okamura J.
    Pediatr Blood Cancer; 2005 Aug; 45(2):111-20. PubMed ID: 15782402
    [Abstract] [Full Text] [Related]

  • 10. Prognostic factors in childhood acute lymphoblastic leukemia in Japan. Japan Association of Childhood Leukemia Study.
    Horibe K, Hara J, Yagi K, Tawa A, Komada Y, Oda M, Nishimura S, Ishikawa Y, Kudoh T, Ueda K.
    Int J Hematol; 2000 Jul; 72(1):61-8. PubMed ID: 10979211
    [Abstract] [Full Text] [Related]

  • 11. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.
    Boissel N, Auclerc MF, Lhéritier V, Perel Y, Thomas X, Leblanc T, Rousselot P, Cayuela JM, Gabert J, Fegueux N, Piguet C, Huguet-Rigal F, Berthou C, Boiron JM, Pautas C, Michel G, Fière D, Leverger G, Dombret H, Baruchel A.
    J Clin Oncol; 2003 Mar 01; 21(5):774-80. PubMed ID: 12610173
    [Abstract] [Full Text] [Related]

  • 12. The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse.
    Unal S, Yetgin S, Cetin M, Gümrük F, Arslan D, Ozyürek E, Tuncer M, Topçu M.
    Pediatr Hematol Oncol; 2004 Mar 01; 21(3):279-89. PubMed ID: 15202168
    [Abstract] [Full Text] [Related]

  • 13. [Prognostic factors for childhood acute non-mature B-lymphoblastic leukemia].
    Jiang H, Gu LJ, Xue HL, Tang JY, Chen J, Pan C, Chen J, Xu C, Dong L, Zhou M.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun 01; 10(3):290-4. PubMed ID: 18554450
    [Abstract] [Full Text] [Related]

  • 14. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
    Magrath I, Shanta V, Advani S, Adde M, Arya LS, Banavali S, Bhargava M, Bhatia K, Gutiérrez M, Liewehr D, Pai S, Sagar TG, Venzon D, Raina V.
    Eur J Cancer; 2005 Jul 01; 41(11):1570-83. PubMed ID: 16026693
    [Abstract] [Full Text] [Related]

  • 15. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
    Kantarjian H, Thomas D, O'Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ.
    Cancer; 2004 Dec 15; 101(12):2788-801. PubMed ID: 15481055
    [Abstract] [Full Text] [Related]

  • 16. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J, Filippa DA, Qin J, Wollner N.
    Cancer; 2003 Sep 15; 98(6):1283-91. PubMed ID: 12973853
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors analysis in a therapeutic trail of acute lymphoblastic leukaemia (ALL).
    Kabir A, Begum M.
    Bangladesh Med Res Counc Bull; 2002 Apr 15; 28(1):19-25. PubMed ID: 12587757
    [Abstract] [Full Text] [Related]

  • 18. Outcome of very late relapse in children with acute lymphoblastic leukemia.
    Rizzari C, Valsecchi MG, Aricò M, Miniero R, Messina C, De Rossi G, Testi AM, Mura R, Galimberti S, Biondi A, Locatelli F, Conter V.
    Haematologica; 2004 Apr 15; 89(4):427-34. PubMed ID: 15075076
    [Abstract] [Full Text] [Related]

  • 19. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
    Takanashi M, Morimoto A, Yagi T, Kuriyama K, Kano G, Imamura T, Hibi S, Todo S, Imashuku S.
    Haematologica; 2003 Nov 15; 88(11):1238-44. PubMed ID: 14607752
    [Abstract] [Full Text] [Related]

  • 20. Outcome of adult acute lymphoblastic leukemia: a single center experience.
    Usman M, Burney I, Nasim A, Adil SN, Salam A, Siddiqui T, Khurshid M.
    J Pak Med Assoc; 2003 Sep 15; 53(9):384-8. PubMed ID: 14620310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.